Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.

By S. Mitra, U. Gaur, P. Ghosh, A. Maitra. Journal of Controlled Release, 2001

627 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Nanoparticle PEGylation for imaging and therapy (2011, background): “Chitons, dextran and other saccharide-containing products have been used to deliver doxorubicin [144,145].”
Targeted delivery of low molecular drugs using chitosan and its derivatives. (2010, methodology): “encapsulated doxorubicin conjugates into cross-linked chitosan nanoparticles using the reverse micellar method [77].”
Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011, methodology): “Chitosan nanoparticles encapsulating doxorubicin–dextran conjugate was prepared by reverse micellar method [144].”
Nanoparticle and targeted systems for cancer therapy. (2004, background): “Treatment with doxorubicin alone did not decrease the tumor volume [30].”
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery (2017, background): “1% chitosan in acetic acid, doxorubicin–dextran conjugate upon continuous stirring at room temperature [118,119].”